Aerin Medical received 510(k) clearance from the FDA for its next-generation RhinAer stylus.

The device uses noninvasive, temperature-controlled radiofrequency technology that durably treats the causes of rhinorrhea or runny nose, post-nasal drip and congestion associated with chronic rhinitis — in a single session.

The updated tool is intended to provide physicians with improved visualization, easier access and tissue apposition, especially in patients with narrow nasal airways.

Other features of the device include a slimmer shaft and tip to improve visualization and access. In addition, the tip tilts backward 10 degrees and the shaft is more malleable.